CaratWire
A round-brilliant-cut diamond solitaire ring in white gold with pavé shoulders, photographed in close-up against a deep blue background
Photo by Koshy Koshy from Faridabad, Haryana, India via Wikimedia Commons

Lab-Grown Diamond Resale Value in 2026: The Per-Carat Reality Check

6/4/2026 · 5 min read

This is a spoke of the hub article Lab-Grown vs Natural Diamonds: what the 2026 price collapse actually means. If you're searching for lab-grown diamond resale values in 2026 specifically — not the general feedback loop, the actual 2026 numbers — here's the per-carat picture.

The 2026 resale price band

Across the four realistic exit routes — jeweler buyback, store-credit upgrade, diamond-buyer cash offer, and peer-to-peer private sale — current cash recovery on a lab-grown stone purchased between 2020 and 2024 is sitting at roughly:

Size band Original retail (approx.) Realistic 2026 cash recovery
0.50–0.99 ct $400–$900 $20–$120
1.00–1.49 ct $900–$2,200 $80–$350
1.50–2.49 ct $1,800–$4,500 $150–$700
2.50–3.99 ct $3,500–$8,000 $300–$1,400
4.00 ct + $7,000–$15,000 $500–$2,500

These are ranges, not quotes. They assume an IGI report, a colorless-to-near-colorless grade, and a peer-to-peer or specialist-buyer exit — the best-case routes. Pawn and jeweler-buyback offers tend to come in at the low end of each row or get declined outright. The deeper structural reason these numbers are where they are is covered in the lab-grown resale reality article — this piece is just the 2026 snapshot.

Why the floor keeps falling

Two specific 2026 data points are doing most of the work:

  1. CVD reactor capacity in India and China has roughly tripled since 2022. Wholesale lab-grown melee (under 0.20 ct) is now under $150 per carat — below the cost of cubic zirconia a decade ago.
  2. De Beers exited the lab-grown jewelry business in 2024, shuttering Lightbox's retail arm specifically to defend natural prices. That removed the only major brand making any attempt to anchor lab-grown retail at a stable number.

Both of those facts compound: capacity expands, marginal cost drops, wholesale follows, retail follows, and the used market — where a buyer can always pick a cheaper new stone next quarter — refuses to clear at any meaningful price. For the choice between growth methods that produced your current stone, see CVD vs HPHT lab diamonds; for the report format question that affects what your stone can be priced against, see IGI vs GIA lab-grown grading.

What this means if you already own one

Four practical takes:

  • If you bought before 2022 and paid natural-adjacent prices, accept that you paid an early-adopter premium that the market has erased. The stone on your hand has not changed; only its replacement cost has.
  • If you're considering selling now to upgrade, the math almost never works. The store credit a jeweler offers as trade-up value is typically 10–30% of what you paid, locked into a larger purchase. You'll do better selling peer-to-peer and putting the cash toward whatever you actually want.
  • If you bought it for the ring on the finger, not the cash value, none of this matters. The stone is the stone.
  • If you're insuring it, insure at replacement value (what an equivalent new stone costs today), not what you paid. Most insurers will accept an updated IGI appraisal at current prices. Replacing a $4,000 2021 stone in 2026 might cost $1,200 — pay the premium on the lower number.

Outside reference

The Antwerp dealer Ajediam tracks weekly lab-grown wholesale movements for the European trade. Their public commentary is one of the few non-US sources publishing actual transaction-level data on lab-grown declines — useful if you want to see whether your local retail benchmark is tracking the wholesale floor or lagging it.

What to ask before selling

"What's your offer in cash, not store credit? Are you pricing this off today's wholesale lab-grown, or off the original IGI report? Is the offer in writing for 30 days?"

If the offer is store credit only — and it usually is — treat the credit as worth roughly half its face value, because it locks you into the next purchase at retail margin.

The one-line summary

In 2026, expect to recover roughly 5–20% of original retail in cash on a lab-grown diamond, depending on size and exit route. The number is not going up. Plan the rest of the purchase decision accordingly.